Medlive Technology Co (FRA:1JZ) Beneish M-Score: -1.68 (As of Aug. 03, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:1JZ Medlive Technology Co Ltd FRA:1JZ
90 GF Score
Price €0.84
GF Value €1.61
! 5 Warning Signs
View Full Analysis

What is Medlive Technology Co Beneish M-Score?

Medlive Technology Co FRA:1JZ +2.93% 90 Beneish M-Score is -1.68 as of Aug. 03, 2026. GuruFocus rates FRA:1JZ with a GF Score™ of 90/100 and a GF Value™ of €1.61. The stock has 5 warning signs investors should review. Among 625 Healthcare Providers & Services companies, Medlive Technology Co ranks worse than 85.12% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.68 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Medlive Technology Co's Beneish M-Score or its related term are showing as below:

FRA:1JZ' s Beneish M-Score Range Over the Past 10 Years
Min: -3.11   Med: -1.7   Max: -1.59
Current: -1.68

During the past 8 years, the highest Beneish M-Score of Medlive Technology Co was -1.59. The lowest was -3.11. And the median was -1.70.


Medlive Technology Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Medlive Technology Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medlive Technology Co Beneish M-Score Chart

Medlive Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial -1.59 -1.72 -2.09 -1.59 -1.68

Medlive Technology Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.09 0.00 -1.59 0.00 -1.68

FRA:1JZ vs VEEV, BTSG, HQY: Beneish M-Score Comparison

For the Health Information Services subindustry, Medlive Technology Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medlive Technology Co Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medlive Technology Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Medlive Technology Co's Beneish M-Score falls into.


FRA:1JZ
90GF Score
Medlive Technology Co Ltd FRA:1JZ
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medlive Technology Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Medlive Technology Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.2546+0.528 * 0.9762+0.404 * 1.5729+0.892 * 1.0629+0.115 * 0.7443
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9031+4.679 * 0.038743-0.327 * 0.9595
=-1.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was €31.73 Mil.
Revenue was €77.86 Mil.
Gross Profit was €46.74 Mil.
Total Current Assets was €483.91 Mil.
Total Assets was €625.30 Mil.
Property, Plant and Equipment(Net PPE) was €3.99 Mil.
Depreciation, Depletion and Amortization(DDA) was €2.56 Mil.
Selling, General, & Admin. Expense(SGA) was €26.32 Mil.
Total Current Liabilities was €25.35 Mil.
Long-Term Debt & Capital Lease Obligation was €0.27 Mil.
Net Income was €40.54 Mil.
Gross Profit was €0.00 Mil.
Cash Flow from Operations was €16.31 Mil.
Total Receivables was €23.79 Mil.
Revenue was €73.25 Mil.
Gross Profit was €42.92 Mil.
Total Current Assets was €571.44 Mil.
Total Assets was €670.03 Mil.
Property, Plant and Equipment(Net PPE) was €4.99 Mil.
Depreciation, Depletion and Amortization(DDA) was €2.05 Mil.
Selling, General, & Admin. Expense(SGA) was €27.41 Mil.
Total Current Liabilities was €27.17 Mil.
Long-Term Debt & Capital Lease Obligation was €1.45 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(31.725 / 77.862) / (23.789 / 73.252)
=0.407452 / 0.324756
=1.2546

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(42.921 / 73.252) / (46.735 / 77.862)
=0.585936 / 0.600229
=0.9762

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (483.909 + 3.988) / 625.299) / (1 - (571.436 + 4.99) / 670.034)
=0.219738 / 0.139706
=1.5729

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=77.862 / 73.252
=1.0629

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(2.046 / (2.046 + 4.99)) / (2.557 / (2.557 + 3.988))
=0.29079 / 0.39068
=0.7443

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(26.316 / 77.862) / (27.413 / 73.252)
=0.337983 / 0.374229
=0.9031

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.267 + 25.354) / 625.299) / ((1.447 + 27.166) / 670.034)
=0.040974 / 0.042704
=0.9595

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(40.539 - 0 - 16.313) / 625.299
=0.038743

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Medlive Technology Co has a M-score of -1.79 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -1.68 mean?
Medlive Technology Co (FRA:1JZ) has a Beneish M-Score of -1.68 as of Aug. 03, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Medlive Technology Co and its competitors. According to the industry distribution chart, Medlive Technology Co ranks #532 out of 625 companies in the Healthcare Providers & Services industry, placing it in the top 85.1%.
Is Medlive Technology Co's Beneish M-Score too high?
Medlive Technology Co's current Beneish M-Score is -1.68. Based on the distribution chart, Medlive Technology Co ranks #532 out of 625 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Medlive Technology Co has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does Medlive Technology Co's Beneish M-Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Medlive Technology Co ranks #532 out of 625 companies for Beneish M-Score. This places Medlive Technology Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Medlive Technology Co and its competitors. Medlive Technology Co's current Beneish M-Score is -1.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medlive Technology Co stock overvalued right now?
Medlive Technology Co (FRA:1JZ) has a current Beneish M-Score of -1.68. The stock's GF Value™ is €1.61, compared to a current price of €0.84 — trading 47.6% below its estimated fair value. The current Beneish M-Score is -1.68. Medlive Technology Co's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Medlive Technology Co (FRA:1JZ), the current Beneish M-Score is -1.68 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medlive Technology Co (FRA:1JZ) Overvalued in 2026?

Based on GuruFocus' analysis, Medlive Technology Co stock appears to be undervalued. The current stock price of €0.84 is trading 47.6% below its estimated GF Value™ of €1.61.

Key valuation signals for FRA:1JZ:

  • Beneish M-Score: -1.68
  • GF Value™: €1.61 vs. price of €0.84 (47.6% below fair value)
  • GF Score™: 90/100 with 5 warning signs

No single metric tells the full story. See the FRA:1JZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medlive Technology Co Business Description

Other Exchanges 02192:Hong Kong
Address Huangqu East Road No. 5, Courtyard Building 4, Yimaitong Mansion, Chaoyang District, Beijing, CHN
Medlive Technology Co Ltd is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms. The company developed into a professional provider of medical information services and precision digital marketing services. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and a SaaS solution that helps with medical conferences and clinical research.
90GF Score

Get the complete analysis for FRA:1JZ

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.84
Price
€1.61
GF Value